Uncle Keith - also gets no respect, page-23

Sanofi/Regeneron are expected to seek approvals for Alirocumab in PFS/AI's at the end of the year. Our Finesse line has not even completed certification so its looking unlikely the initial FDA submissions will involve our products. However, over time I cant see why Sanofi/Regeneron wouldnt move Alirocumab over to Finesse.

Its a pity Uncle Keith doesn't explain or explore our ability to supply goods within Sanofi/Regeneron's end of year timeline.